Rapid resolution of liver metastasis from cholangiocarcinoma after bevacizumab with cisplatin and high-dose fluorouracil plus leucovorin

Onkologie

Volumn 29, Issue 4, 2006, Pages 179-180

  Tai, Cheng Jeng ^a   Chiou, Hung Yi ^a   Wu, Chih Hsiung ^a   Pan, Shiann ^a   Liu, Jean Dean ^a  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; BILE DUCT CARCINOMA; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DRUG MEGADOSE; ECHOGRAPHY; FEVER; HUMAN; LETTER; LIVER METASTASIS; MALE; SEPTICEMIA;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHOLANGIOCARCINOMA; CISPLATIN; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 33645664294     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091751     Document Type: Letter

References (2)

1. Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F: Bevacizumab in combination with nuorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 2005;23:3502-3508.
2. Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Hecht JR, Mass R, Perrou B, Nelson B, Novotny WF: Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 2005;23:3697-3705.